Somapacitan Treatment in Children and Adolescents Born SGA: Two-Year Efficacy and Preference Over Daily GH.

Maniatis A, Böttcher V, Højby M, Frystyk J, Cheng X, Kashimada K, Krogh Lemminger A, Longui CA, Silverman L, Soltysik K, Linglart A

Open source

DOI
10.1210/clinem/dgag430
Published
2026 Oct 29
Container
The Journal of clinical endocrinology and metabolism
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1210/clinem/dgag430,
  title = {Somapacitan Treatment in Children and Adolescents Born SGA: Two-Year Efficacy and Preference Over Daily GH.},
  author = {Maniatis A and Böttcher V and Højby M and Frystyk J and Cheng X and Kashimada K and Krogh Lemminger A and Longui CA and Silverman L and Soltysik K and Linglart A},
  year = {2026},
  journal = {The Journal of clinical endocrinology and metabolism},
  doi = {10.1210/clinem/dgag430},
  url = {https://doi.org/10.1210/clinem/dgag430}
}

RIS

TY  - JOUR
TI  - Somapacitan Treatment in Children and Adolescents Born SGA: Two-Year Efficacy and Preference Over Daily GH.
AU  - Maniatis A
AU  - Böttcher V
AU  - Højby M
AU  - Frystyk J
AU  - Cheng X
AU  - Kashimada K
AU  - Krogh Lemminger A
AU  - Longui CA
AU  - Silverman L
AU  - Soltysik K
AU  - Linglart A
PY  - 2026
JO  - The Journal of clinical endocrinology and metabolism
DO  - 10.1210/clinem/dgag430
UR  - https://doi.org/10.1210/clinem/dgag430
ER  - 

APA

A, M., V, B., M, H., J, F., X, C., K, K., A, K. L., CA, L., L, S., K, S., & A, L. (2026). Somapacitan Treatment in Children and Adolescents Born SGA: Two-Year Efficacy and Preference Over Daily GH.. The Journal of clinical endocrinology and metabolism. https://doi.org/10.1210/clinem/dgag430

Source records